Maurizio Aricò
- Hematology top 0.02%
- Autoimmune and Inflammatory Disorders Research 54
- Acute Myeloid Leukemia Research 29
- Infectious Diseases top 0.1%
- Parvovirus B19 Infection Studies 44
- Immunology top 0.2%
- Immune Cell Function and Interaction 39
- Speech and Hearing top 0.1%
- Physiology top 0.5%
- Histiocytic Disorders and Treatments 51
-
- Acute Lymphoblastic Leukemia research 64
-
- Childhood Cancer Survivors' Quality of Life 40
-
- Viral-associated cancers and disorders 23
- Co-authors
- Jan‐Inge HenterGritta JankaStephan LadischShinsaku ImashukuAlexandra H. FilipovichKenneth L. McClainDavid WebbAnnaCarin Horne
- Journals
- New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)Nature Medicine (1 paper)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Maurizio Aricò
303 papers receiving 16.0k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Hematology 8.5k
- Infectious Diseases 5.8k
- Immunology 6.0k
- Speech and Hearing 1.0k
- Physiology 3.6k
Countries citing papers authored by Maurizio Aricò
This map shows the geographic impact of Maurizio Aricò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurizio Aricò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurizio Aricò more than expected).
Fields of papers citing papers by Maurizio Aricò
This network shows the impact of papers produced by Maurizio Aricò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurizio Aricò. The network helps show where Maurizio Aricò may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maurizio Aricò, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 2 | |
| 6 | 2018 | 15 | |
| 7 | 2017 | 16 | |
| 8 | 2015 | 90 | |
| 9 | 2014 | 17 | |
| 10 | 2013 | 14 | |
| 11 | 2013 | 27 | |
| 12 | 2012 | 36 | |
| 13 | 2012 | 61 | |
| 14 | 2009 | 181 | |
| 15 | Bifocal manifestation of eosinophilic granuloma in a paediatric patient-A case report | 2009 | 1 |
| 16 | HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosisbreakdown → | 2006 | 3420 |
| 17 | 2005 | 154 | |
| 18 | 2002 | 47 | |
| 19 | Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. | 1998 | 41 |
| 20 | 1995 | 68 |
About Maurizio Aricò
Maurizio Aricò is a scholar working on Hematology, Infectious Diseases and Immunology, having authored 315 papers that have together received 16.5k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (64 papers), Autoimmune and Inflammatory Disorders Research (54 papers), Histiocytic Disorders and Treatments (51 papers), Parvovirus B19 Infection Studies (44 papers), Childhood Cancer Survivors' Quality of Life (40 papers), Immune Cell Function and Interaction (39 papers), Acute Myeloid Leukemia Research (29 papers) and Viral-associated cancers and disorders (23 papers). The work is most often cited by research in Hematology (8.5k citations), Infectious Diseases (5.8k citations) and Immunology (6.0k citations). Maurizio Aricò has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Jan‐Inge Henter, Gritta Janka, Stephan Ladisch, Shinsaku Imashuku, Alexandra H. Filipovich, Kenneth L. McClain, David Webb, AnnaCarin Horne, R. Maarten Egeler and Jacek Winiarski. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.